30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Pathological priming causes developmental gene network heterochronicity in autism patient-derived neurons

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Autism spectrum disorder (ASD) is thought to emerge during early cortical development. However, the exact developmental stages and associated molecular networks that prime disease propensity are elusive. To profile early neurodevelopmental alterations in ASD with macrocephaly, we monitored patient-derived induced pluripotent stem cells (iPSCs) throughout the recapitulation of cortical development. Our analysis revealed ASD-associated changes in the maturational sequence of early neuron development, involving temporal dysregulation of specific gene networks and morphological growth acceleration. The observed changes tracked back to a pathologically primed stage in neural stem cells (NSCs), reflected by altered chromatin accessibility. Concerted overrepresentation of network factors in control NSCs was sufficient to trigger ASD-like features, and circumventing the NSC stage by direct conversion of ASD iPSCs into induced neurons (iPSC-iNs) abolished ASD-associated phenotypes. Our findings identify heterochronic dynamics of a gene network that, while established earlier in development, contributes to subsequent neurodevelopmental aberrations in ASD.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: found
          • Article: not found

          Gene Ontology: tool for the unification of biology

          Genomic sequencing has made it clear that a large fraction of the genes specifying the core biological functions are shared by all eukaryotes. Knowledge of the biological role of such shared proteins in one organism can often be transferred to other organisms. The goal of the Gene Ontology Consortium is to produce a dynamic, controlled vocabulary that can be applied to all eukaryotes even as knowledge of gene and protein roles in cells is accumulating and changing. To this end, three independent ontologies accessible on the World-Wide Web (http://www.geneontology.org) are being constructed: biological process, molecular function and cellular component.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Direct conversion of fibroblasts to functional neurons by defined factors

            Cellular differentiation and lineage commitment are considered robust and irreversible processes during development. Recent work has shown that mouse and human fibroblasts can be reprogrammed to a pluripotent state with a combination of four transcription factors. This raised the question of whether transcription factors could directly induce other defined somatic cell fates, and not only an undifferentiated state. We hypothesized that combinatorial expression of neural lineage-specific transcription factors could directly convert fibroblasts into neurons. Starting from a pool of nineteen candidate genes, we identified a combination of only three factors, Ascl1, Brn2, and Myt1l, that suffice to rapidly and efficiently convert mouse embryonic and postnatal fibroblasts into functional neurons in vitro. These induced neuronal (iN) cells express multiple neuron-specific proteins, generate action potentials, and form functional synapses. Generation of iN cells from non-neural lineages could have important implications for studies of neural development, neurological disease modeling, and regenerative medicine.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Rapid single-step induction of functional neurons from human pluripotent stem cells.

              Available methods for differentiating human embryonic stem cells (ESCs) and induced pluripotent cells (iPSCs) into neurons are often cumbersome, slow, and variable. Alternatively, human fibroblasts can be directly converted into induced neuronal (iN) cells. However, with present techniques conversion is inefficient, synapse formation is limited, and only small amounts of neurons can be generated. Here, we show that human ESCs and iPSCs can be converted into functional iN cells with nearly 100% yield and purity in less than 2 weeks by forced expression of a single transcription factor. The resulting ES-iN or iPS-iN cells exhibit quantitatively reproducible properties independent of the cell line of origin, form mature pre- and postsynaptic specializations, and integrate into existing synaptic networks when transplanted into mouse brain. As illustrated by selected examples, our approach enables large-scale studies of human neurons for questions such as analyses of human diseases, examination of human-specific genes, and drug screening. Copyright © 2013 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Journal
                9809671
                21092
                Nat Neurosci
                Nat. Neurosci.
                Nature neuroscience
                1097-6256
                1546-1726
                26 February 2019
                07 January 2019
                February 2019
                07 July 2019
                : 22
                : 2
                : 243-255
                Affiliations
                [1 ]Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, California, USA
                [2 ]Lieber Institute for Brain Development, Baltimore, Maryland, USA
                [3 ]Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
                [4 ]Centre de Recherche du Centre Hospitalier Universitaire (CHU) de Québec–Université Laval, Département de Médecine Moléculaire, Faculté de Médecine, Université Laval, Québec, Canada
                [5 ]Next Generation Sequencing Core, The Salk Institute for Biological Studies, La Jolla, California, USA
                [6 ]Division of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, Faculty of Medicine, University of Freiburg, Germany
                [7 ]Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California, USA
                [8 ]Department of Genomics, Stem Cell Biology and Regenerative Medicine, Institute of Molecular Biology & CMBI, University of Innsbruck, Innsbruck, Austria
                Author notes
                [* ] Corresponding Author Correspondence to Fred H. Gage ( gage@ 123456salk.edu )

                Contributions

                S.T.S. designed, performed, analyzed and contributed to all experiments. A.P. aligned the RNA-seq dataset, performed statistical analysis and helped with data interpretation. S.S. conducted and analyzed the electrophysiological recording experiments. M.K. performed RNA-seq experiments and helped with interpretation of results. D.G. performed ATAC-seq experiments. D.G. and C.K.G. analyzed data and helped with interpretation of results. M.P. conducted flow cytometry, imaging experiments, analyzed data and assisted with tissue culture and organoid experiments. M.L. and T.K. conducted structural and morphological analysis and performed cloning experiments. A.M. helped with organoid experiments and analyzed data. B.J. contributed to flow cytometry analysis. C.M. provided iPSC lines and helped with data interpretation. J.M. provided constructs, assisted with establishment of iPSC-iN protocol and helped with data interpretation. F.H.G. supervised the experimental design and analysis, interpreted results and provided funding. S.T.S. and F.H.G. wrote the manuscript and conceptualized the study.

                Present Addresses

                Lieber Institute for Brain Development, Baltimore, Maryland, USA

                Apua C.M. Paquola

                Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

                Apua C.M. Paquola

                Centre de Recherche du Centre Hospitalier Universitaire (CHU) de Québec–Université Laval, Département de Médecine Moléculaire, Faculté de Médecine, Université Laval, Québec, Canada

                David Gosselin

                Division of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, Faculty of Medicine, University of Freiburg, Germany

                Manching Ku

                Laboratory of Neural Plasticity, Faculties of Medicine and Science, Brain Research Institute, University of Zurich, Zurich, Switzerland

                Baptiste N. Jaeger

                Department of Genomics, Stem Cell Biology and Regenerative Medicine, Institute of Molecular Biology & CMBI, University of Innsbruck, Innsbruck, Austria

                Jerome Mertens

                Article
                NIHMS1512664
                10.1038/s41593-018-0295-x
                6402576
                30617258
                87130ef6-41f6-4443-a1cd-bc0c0b814ed1

                Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Neurosciences
                Neurosciences

                Comments

                Comment on this article